1 / 16

POG – 8651 neoadjuvant chemo vs. immediate surgery and adjuvant chemo

Effects of Neoadjuvant Chemotherapy on Image-directed Planning of Surgical Resection for Distal Femur Osteosarcoma. Kevin B. Jones, Brian Lam, Anthony M. Griffin, Yair Gortzak, Kevan Saidi, Michael C. Biddulph, Majid Al-Yamani, Lawrence White, Benjamin Deheshi, Sevan Hopyan,

sierra
Download Presentation

POG – 8651 neoadjuvant chemo vs. immediate surgery and adjuvant chemo

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Effects of Neoadjuvant Chemotherapy on Image-directed Planning of Surgical Resection for Distal Femur Osteosarcoma Kevin B. Jones, Brian Lam, Anthony M. Griffin, Yair Gortzak, Kevan Saidi, Michael C. Biddulph, Majid Al-Yamani, Lawrence White, Benjamin Deheshi, Sevan Hopyan, Peter C. Ferguson, Jay S. Wunder

  2. POG – 8651neoadjuvant chemo vs. immediate surgery and adjuvant chemo • Intended 4 year accrual for 215 patients • Only 20 patients enrolled in first year • Down-sized to non-inferiority model with110 patients • After 7 years accrual, only 106 patients, 6 exlcuded • NO SIGNIFICANT DIFFERENCES 69±8% survival for immediate surgery 61±6% survival for neoadjuvant

  3. Effects of Neoadjuvant Chemotherapy on Local Disease • Volume reduction? • Clearing of peritumoral edema? • Creation of a reactive rind/capsule?

  4. Questions • Can surgeons consistently evaluate an MRI and plan a surgical resection? • Will that planned resection change from pre-chemotherapy to post-chemotherapy MRIs?

  5. Methods • 24 patients with distal femur osteosarcoma • Pre- and post-chemo MRIs, blinded • 4 faculty sarcoma surgeons • Surgical planning assessment form

  6. Surgical Planning Record • What type of surgical resection: • Hip disarticulation; amputation; borderline limb salvage; safe limb salvage • Expected myectomies: • % of each regional muscle • Expected neurovascular margins: • Millimeter distance from each structure • Expected soft-tissue coverage: • Anticipated need for flaps and grafts • Guess at MRI timing: • pre- or post-chemo

  7. Other Assessments • Each surgeon repeated surgical planning for 5 blinded scans • 4 sarcoma surgery fellows evaluated scans from 5 patients • Each MRI was also evaluated by two experienced musculoskeletal radiologists

  8. Statistics • Intra-class correlation coefficients for intra-rater and inter-rater reliability • Student’s t-test for continuous variables pre- to post-chemo • Fisher’s Exact test for categorical variables pre- to post-chemo

  9. Results: Intra-rater reliability • Mean ICCs showed strong reliability • Surgeon 1: 0.794 (95%CI 0.692-0.865) • Surgeon 2: 0.597 (95%CI 0.429-0.725) • Surgeon 3: 0.889 (95%CI 0.829-0.928) • Surgeon 4: 0.832 (95%CI 0.745-0.884)

  10. Results: Inter-rater reliability • Among faculty surgeons: ICC = 0.772 (95%CI 0.736-0.886) • Among faculty + fellow surgeons: ICC = 0.605 (95%CI 0.540-0.671)

  11. Conclusions #1 • Surgeons can reliably record an intended surgical resection from an MRI • The details of that surgical resection are more determined by characteristics of the tumor anatomy than of surgeon preferences

  12. Results: Pre- to Post-chemo • Many tumors changed in each direction • Net changes across the group were not statistically significant • Most trends were toward bigger, more risky surgeries after chemotherapy

  13. Hip Disarticulation AKA Borderline Limb-salvage Safe Limb-salvage Pre-chemotherapy MRI Post-chemotherapy MRI

  14. Of Note • Only 4 were poor responders (50% or less necrosis) histologically • 4 were fair responders (51-90% necrosis)

  15. Conclusions #2 • In terms of the anatomic parameters of surgical resection, osteosarcomas as a group are not favorably affected by neoadjuvant chemotherapy

  16. Thanks!

More Related